Evidence map›Paper›PMID 35796141›Full record

ArticleInvestigative and clinical urology2022

Pericyte-derived heme-binding protein 1 promotes angiogenesis and improves erectile function in diabetic mice.

Guo Nan Yin

Open access · diamondAbstract read
In one paragraph

Article in Investigative and clinical urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Guo Nan YinDepartment of Urology, National Research Center for Sexual Medicine, Inha University School of Medicine, Incheon, Korea. 217052@inha.ac.kr.ORCID 0000-0002-2512-7337
Inha University · KR

Funding

Inha University
6 · The paper itself

Abstract

purposeTo comprehensively evaluate the effect on angiogenesis of heme-binding protein 1 (Hebp1) in the treatment of diabetes-induced erectile dysfunction. MATERIALS AND

methodsMouse corpus cavernosum endothelial cells and pericytes were used for

resultsWe report that Hebp1 is more highly expressed in mouse corpus cavernosum pericytes and can effectively promote endothelial cell angiogenesis under high-glucose conditions. Following exogenous administration of Hebp1 protein, we found that elevated Hebp1 levels can improve the erectile function of diabetic mice, which is achieved by reducing reactive oxygen species levels and activating the PI3K/AKT/eNOS signaling pathway.

conclusionsOur findings demonstrate that Hebp1 can promote angiogenesis and improve erectile function under diabetic conditions.

Indexed as

Diabetes Mellitus, ExperimentalErectile DysfunctionAnimalsEndothelial CellsHeme-Binding ProteinsHumansMaleMiceMice, Inbred C57BLPericytesPhosphatidylinositol 3-KinasesHeme-Binding ProteinsPhosphatidylinositol 3-KinasesDiabetes mellitusErectile dysfunctionHeme-binding proteinsPericytes

Identifiers

PMID35796141
PMCPMC9262492
OpenAlexW4284888899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.